iSpecimen Unveils Enhanced iSpecimen Marketplace Platform to Help Scientists More Efficiently Find Desired Biospecimens for Research
April 26 2022 - 7:30AM
iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a
global, online marketplace that connects scientists in need of
biospecimens for medical research with a network of healthcare
providers who have them, today unveiled its enhanced iSpecimen
Marketplace
® platform. The new software includes
improved search and supplier data integration capabilities that
have been designed to efficiently connect scientists with
well-matched samples for their research, as well as help to
increase supplier inventory utilization.
The platform’s redesigned, easy-to-use interface
allows researchers to directly search for desired samples in
iSpecimen’s provider network via a Google-like search bar. The
technology utilizes researcher-specified broad or exact matching
algorithms to find the precise human biospecimens that researchers
need. Augmenting this updated search capability are facets that
guide researchers to further refine their results. The search
functionality now includes new data fields that can be accessed
along with other features, such as multi-select and in-facet
search, to enable a more powerful specimen matching capability.
A graphic accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/2aef4423-9f95-4db6-b9e9-77c29d78b518
The iSpecimen Marketplace also includes new
features that enable specimen providers, including biobanks, to
more effectively provide their specimens to researchers. Suppliers
can now use the iSpecimen Marketplace technology to search their
own inventory and easily find specimens that meet criteria for
internal research requests. Additionally, new data integration
capabilities, such as automated data harmonization and ingestion
tools, allow healthcare providers’ inventories to be added quickly
and maintained easily. Access to the iSpecimen Marketplace platform
is free for participating suppliers and researchers alike upon
signup.
Other new iSpecimen Marketplace features include
expanded searchable data, such as smoking and alcohol history of
the person from whom the sample was collected, and synonym support,
which allows users to type common words into the search bar that
will then automatically match to synonymous values stored in the
iSpecimen Marketplace.
“For researchers around the world, obtaining
quality specimens in a timely manner has never been an easy feat,
and simplification starts with the search function,” said Dr.
Christopher Ianelli, M.D., Ph.D., iSpecimen Founder and CEO. “Since
the Company’s inception, demand for our iSpecimen Marketplace
continues to grow. As such, we have worked vigorously to continue
innovating our search function to streamline access to
biospecimens, patients and data that are critical to advancing
medical research and delivering results that align with precise
banked specimen requirements. We look forward to continuing to make
strategic, large-scale investments in the iSpecimen Marketplace
that will optimize search results and assist researchers in need of
specimens for critical research across the world. This is just the
first in a series of developments that will help take biospecimen
matchmaking and procurement to new heights.”
About iSpecimen iSpecimen
(Nasdaq: ISPC) offers an online marketplace for human biospecimens,
connecting scientists in commercial and non-profit organizations
with healthcare providers that have access to patients and
specimens needed for medical discovery. Proprietary, cloud-based
technology enables scientists to intuitively search for specimens
and patients across a federated partner network of hospitals, labs,
biobanks, blood centers and other healthcare organizations. For
more information, please visit www.ispecimen.com.
Forward Looking Statements This
press release may contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
Such forward-looking statements are characterized by future or
conditional verbs such as "may," "will," "expect," "intend,"
"anticipate," “believe," "estimate" and "continue" or similar
words. You should read statements that contain these words
carefully because they discuss future expectations and plans, which
contain projections of future results of operations or financial
condition or state other forward-looking information.
Forward-looking statements are predictions,
projections and other statements about future events that are based
on current expectations and assumptions and, as a result, are
subject to risks and uncertainties. Many factors could cause actual
future events to differ materially from the forward-looking
statements in this press release, including but not limited to the
risk factors contained in the Company's filings with the Securities
and Exchange Commission, which are available for review at
www.sec.gov. Forward-looking statements speak only as of the date
they are made. New risks and uncertainties arise over time, and it
is not possible for the Company to predict those events or how they
may affect the Company. If a change to the events and circumstances
reflected in the Company's forward-looking statements occurs, the
Company's business, financial condition and operating results may
vary materially from those expressed in the Company's
forward-looking statements.
Readers are cautioned not to put undue reliance on
forward-looking statements, and the Company assumes no obligation
and do not intend to update or revise these forward-looking
statements, whether as a result of new information, future events
or otherwise.
For further information, please
contact:
Investor Contact KCSA Strategic
Communications Allison Soss iSpecimen@kcsa.com
Media Contacts KCSA Strategic
Communications Raquel Cona / Shana Marino iSpecimen@kcsa.com
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Apr 2023 to Apr 2024